Drug Shortage Report for TARO-BUDESONIDE
| Report ID | 173511 |
| Drug Identification Number | 02494280 |
| Brand name | TARO-BUDESONIDE |
| Common or Proper name | BUDESONIDE |
| Company Name | TARO PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | BUDESONIDE |
| Strength(s) | 0.5MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INHALATION |
| Packaging size | 2 |
| ATC code | R03BA |
| ATC description | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-04-14 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-01-28 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.